Patents by Inventor Michael W. Mueting

Michael W. Mueting has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210129098
    Abstract: Disclosed herein are powder mixing apparatuses and methods that utilize the deagglomerizing and mixing effects of an air flow that impacts a flowing powder. The resulting powder can have smaller particle sizes and/or exhibit a more homogenous mixture than the premixed powder.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 6, 2021
    Inventors: Stephen W. Stein, Michael W. Mueting, Herbert C. Chiou, James S. Stefely
  • Patent number: 10919011
    Abstract: Disclosed herein are powder mixing apparatuses and methods that utilize the deagglomerizing and mixing effects of an air flow that impacts a flowing powder. The resulting powder can have smaller particle sizes and/or exhibit a more homogenous mixture than the premixed powder.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: February 16, 2021
    Assignee: Adamis Pharmaceuticals Corporation
    Inventors: Stephen W. Stein, Michael W. Mueting, Herbert C. Chiou, James S. Stefely
  • Publication number: 20190054435
    Abstract: Disclosed herein are powder mixing apparatuses and methods that utilize the deagglomerizing and mixing effects of an air flow that impacts a flowing powder. The resulting powder can have smaller particle sizes and/or exhibit a more homogenous mixture than the premixed powder.
    Type: Application
    Filed: October 19, 2018
    Publication date: February 21, 2019
    Inventors: Stephen W. Stein, Michael W. Mueting, Herbert C. Chiou, James S. Stefely
  • Patent number: 10188996
    Abstract: Disclosed herein are powder mixing apparatuses and methods that utilize the deagglomerizing and mixing effects of an air flow that impacts a flowing powder. The resulting powder can have smaller particle sizes and/or exhibit a more homogenous mixture than the premixed powder.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: January 29, 2019
    Assignee: Adamis Pharmaceuticals Corporation
    Inventors: Stephen W. Stein, Michael W. Mueting, Herbert C. Chiou, James S. Stefely
  • Publication number: 20180235880
    Abstract: A method of making a dry powder pharmaceutical composition comprising: providing inactive ingredient particles; providing a micronized active ingredient; mixing the inactive ingredient particles with surface-modified nanoparticles to provide an inactive ingredient comprised of particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; and/or mixing the micronized active ingredient with surface-modified nanoparticles to provide a micronized active ingredient comprised of particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; and then mixing the micronized active ingredient with the inactive ingredient; the dry powder compositions made by the method; a method of delivering medicament to the lungs of a mammal by administering a therapeutic amount of the dry powder pharmaceutical composition, and a dry powder inhalation device comprising a mouth piece, a powder containment system, and the dry powder pharmaceutical composition are disclosed.
    Type: Application
    Filed: April 24, 2018
    Publication date: August 23, 2018
    Inventors: ADAM S. CANTOR, JACQUELINE M. GANSER, MICHAEL W. MUETING, STEPHEN W. STEIN
  • Patent number: 9956170
    Abstract: A method of making a dry powder pharmaceutical composition comprising: providing inactive ingredient particles; providing a micronized active ingredient; mixing the inactive ingredient particles with surface-modified nanoparticles to provide an inactive ingredient comprised of particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; and/or mixing the micronized active ingredient with surface-modified nanoparticles to provide a micronized active ingredient comprised of particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; and then mixing the micronized active ingredient with the inactive ingredient; the dry powder compositions made by the method; a use of said composition for the manufacture of a medicament for being delivered to the lungs of a mammal by administering a therapeutic amount of the dry powder pharmaceutical composition, and a dry powder inhalation device comprising a mouth piece, a powder containment system, and the dry po
    Type: Grant
    Filed: June 22, 2009
    Date of Patent: May 1, 2018
    Assignee: 3M Innovative Properties Company
    Inventors: Adam S. Cantor, Jacqueline M. Ganser, Michael W. Mueting, Stephen W. Stein
  • Patent number: 9861580
    Abstract: A method of making active pharmaceutical ingredient particles with surface-modified nanoparticles deposited on the particles' surfaces, the method comprising: providing a plurality of media particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; mixing the plurality of media particles with the active ingredient particles, both of which are in dry form, to provide active ingredient particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; and separating the plurality of media particles from the active ingredient particles having surfaces with the surface-modified nanoparticles deposited on the surfaces is disclosed.
    Type: Grant
    Filed: June 22, 2009
    Date of Patent: January 9, 2018
    Assignee: 3M Innovative Properties Company
    Inventors: Michael W. Mueting, Daniel C. Duan, Stephen W. Stein
  • Publication number: 20170095782
    Abstract: Disclosed herein are powder mixing apparatuses and methods that utilize the deagglomerizing and mixing effects of an air flow that impacts a flowing powder. The resulting powder can have smaller particle sizes and/or exhibit a more homogenous mixture than the premixed powder.
    Type: Application
    Filed: October 2, 2015
    Publication date: April 6, 2017
    Inventors: Stephen W. Stein, Michael W. Mueting, Herbert C. Chiou, James S. Stefely
  • Patent number: 9072664
    Abstract: Powder drug compositions exhibiting improved flow properties are manufactured by spraying a suspension of surface-modified nanoparticles having an average particle size diameter of less than 100 nm in a dryable liquid carrier onto particles of a powder ingredient of a drug composition. The liquid carrier is rapidly dried so as to leave the nanoparticles on the powder. Other ingredients of the powder drug composition can also be added.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: July 7, 2015
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Stephen W. Stein, Michael W. Mueting, Timothy D. Dunbar
  • Publication number: 20110104362
    Abstract: A method of making active pharmaceutical ingredient particles with surface-modified nanoparticles deposited on the particles' surfaces, the method comprising: providing a plurality of media particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; mixing the plurality of media particles with the active ingredient particles, both of which are in dry form, to provide active ingredient particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; and separating the plurality of media particles from the active ingredient particles having surfaces with the surface-modified nanoparticles deposited on the surfaces is disclosed.
    Type: Application
    Filed: June 22, 2009
    Publication date: May 5, 2011
    Inventors: Michael W. Mueting, Daniel C. Duan, Stephen W. Stein
  • Publication number: 20110076336
    Abstract: A method of making a dry powder pharmaceutical composition comprising: providing inactive ingredient particles; providing a micronized active ingredient; mixing the inactive ingredient particles with surface-modified nanoparticles to provide an inactive ingredient comprised of particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; and/or mixing the micronized active ingredient with surface-modified nanoparticles to provide a micronized active ingredient comprised of particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; and then mixing the micronized active ingredient with the inactive ingredient; the dry powder compositions made by the method; a use of said composition for the manufacture of a medicament for being delivered to the lungs of a mammal by administering a therapeutic amount of the dry powder pharmaceutical composition, and a dry powder inhalation device comprising a mouth piece, a powder containment system, and the dry po
    Type: Application
    Filed: June 22, 2009
    Publication date: March 31, 2011
    Inventors: Adam S. Cantor, Jacqueline M. Ganser, Michael W. Mueting, Stephen W. Stein
  • Publication number: 20110064867
    Abstract: Powder drug compositions exhibiting improved flow properties are manufactured by spraying a suspension of surface-modified nanoparticles having an average particle size diameter of less than 100 nm in a dryable liquid carrier onto particles of a powder ingredient of a drug composition. The liquid carrier is rapidly dried so as to leave the nanoparticles on the powder. Other ingredients of the powder drug composition can also be added.
    Type: Application
    Filed: April 17, 2009
    Publication date: March 17, 2011
    Inventors: Stephen W. Stein, Michael W. Mueting, Timothy D. Dunbar
  • Patent number: 7659725
    Abstract: A method of assessing the suitability of a metered dose inhaler actuator A test canister equipped with a valve and containing a pressurized propellant is provided. One or more actuators manufactured for use in a metered dose inhaler is provided and tested, wherein each actuator is tested by coupling the canister to the actuator, positioning the actuator with respect to an electrostatic measurement device and firing the canister such that electrostatic charge from an aerosol emitted by the canister is measured by the electrostatic measurement device. The measured electrostatic charge is compared to a predetermined specification range to make a determination whether the measured electrostatic charge is within or outside the predetermined specification range and accordingly whether the actuator is or is not acceptable.
    Type: Grant
    Filed: March 22, 2007
    Date of Patent: February 9, 2010
    Assignee: 3M Innovative Properties Company
    Inventors: Michael W. Mueting, Stephen W. Stein
  • Publication number: 20090121722
    Abstract: A method of assessing the suitability of a metered dose inhaler actuator A test canister equipped with a valve and containing a pressurized propellant is provided. One or more actuators manufactured for use in a metered dose inhaler is provided and tested, wherein each actuator is tested by coupling the canister to the actuator, positioning the actuator with respect to an electrostatic measurement device and firing the canister such that electrostatic charge from an aerosol emitted by the canister is measured by the electrostatic measurement device. The measured electrostatic charge is compared to a predetermined specification range to make a determination whether the measured electrostatic charge is within or outside the predetermined specification range and accordingly whether the actuator is or is not acceptable.
    Type: Application
    Filed: March 22, 2007
    Publication date: May 14, 2009
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Michael W. Mueting, Stephen W. Stein